American Chemical Society--233rd National Meeting. Novel drugs for the treatment of cancer. 25-29 March 2007, Chicago, IL, USA.
Turner
Ben
B
Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE, UK. ben.turner@thomson.com
Bright
Jonathan
J
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D000071877:Checkpoint Kinase 1; D016503:Drug Delivery Systems; D004354:Drug Screening Assays, Antitumor; D015507:Drugs, Investigational; D000080890:Duocarmycins; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D007211:Indoles / Q000737:chemistry; D009369:Neoplasms / Q000188:drug therapy*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011092:Polyethylene Glycols / Q000737:chemistry; D011494:Protein Kinases; D017526:Receptor, IGF Type 1 / Q000037:antagonists & inhibitors
D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D000080890:Duocarmycins; D004791:Enzyme Inhibitors; D007211:Indoles; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011092:Polyethylene Glycols; C018782:CC 1065; D011494:Protein Kinases; D017526:Receptor, IGF Type 1; D000071877:Checkpoint Kinase 1